William P. Tew

Aug 19, 2024 | ascopost.com | Tiffany Sia |William P. Tew |Jennifer Mueller

Endometrial cancer is most frequently diagnosed among women aged 55 to 65, with a median age at diagnosis of 64 years.1 In epidemiologic studies, women diagnosed with endometrial cancer at an older age are more likely to have high-grade disease, aggressive histology, deep myometrial invasion, lower uterine segment involvement, and advanced disease.2,3 All of these factors increase the need for adjuvant treatment and are associated with higher rates of disease recurrence.

Dec 16, 2023 | acsjournals.onlinelibrary.wiley.com | Melissa Lumish |Elise C. Kohn |William P. Tew

CONFLICT OF INTEREST STATEMENT The authors declared no conflicts of interest. REFERENCES 1, , , et al. Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline. J Clin Oncol. 2020; 38(11): 1222-1245. 2, , , et al. LBA33 Maintenance olaparib rechallenge in patients (pts) with ovarian carcinoma (OC) previously treated with a PARP inhibitor (PARPi): phase IIIb OReO/ENGOT Ov-38 trial [abstract]. Ann Oncol. 2021; 32(suppl 5): S1308-S1309.